Announced Fri, 26 Jun · 20:15 IST
Newspaper notice for Umang Vohra as Chairman and CEO appointment
Compliance View source PDF
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.8%1-day move
₹456.60
prior close
₹456.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.4-1.0-1.2+0.4-0.8-1.3-0.4-0.5-1.4-4.9-1.6———
Up moveDown movePending
AI summary
Cohance Lifesciences has published a notice in Business Standard and Navashakti seeking Central Government approval under Section 201 of the Companies Act 2013 for appointing Mr Umang Vohra (Non-Resident) as Director, Chairman and Group CEO from 1 May 2026 to 30 April 2031. Board approved on 27 April 2026 and shareholders approved via Postal Ballot on 13 June 2026.
Likely market impact
Procedural regulatory filing to formalise Mr Vohra leadership roles. No direct material impact on financials.